Coronavirus disease (COVID-19) chilblains is a well-reported cutaneous pattern of severe acute respiratory syndrome coronavirus (SARS-CoV-2). Through this narrative review, we provide an evidence-based overview of idiopathic and secondary chilblains, distinguishing features of COVID-19 chilblains, and a systematic clinical approach to history, examination, investigations, and treatment. In the absence of cold or damp exposure, COVID-19 should be considered as a cause of acute chilblains. The timing of onset of COVID-19 chilblains relative to active SARS-CoV-2 viremia remains unclear. Patients with suspected COVID-19 chilblains should thus follow public health guidelines for COVID-19 testing and self-isolation.
DuongTA.VelterC.RybojadMet al. Did Whatsapp. J Eur Acad Dermatol Venereol. 2020
2.
AhouachB.HarantS.UllmerAet al. Cutaneous lesions in a patient with COVID-19: are they related?Br J Dermatol. 2020doi:10.1111/bjd.19168 30 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32353170
3.
AlramthanA.AldarajiW. Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the middle East. Clin Exp Dermatol. 2020doi:10.1111/ced.14243 17 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32302422
4.
AndinaD.Noguera-MorelL.Bascuas-ArribasMet al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020doi:10.1111/pde.14215 09 May 2020.http://www.ncbi.nlm.nih.gov/pubmed/32386460
5.
Avellana MorenoR.Estela VillaLM.Avellana MorenoV.Estela VillaC.Moreno AparicioMA.Avellana FontanellaJA. Cutaneous manifestation of COVID-19 in images: a case report. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16531 24 Apr 2020.32330339
6.
CastelnovoL.CapelliF.TamburelloA.FaggioliPM.MazzoneA. Symmetric cutaneous vasculitis in COVID-19 pneumonia. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16589 07 May 2020.http://www.ncbi.nlm.nih.gov/pubmed/32378747
7.
Cepeda-ValdesR.Carrion-AlvarezD.Trejo-CastroA.Hernandez-TorreM.Salas‐AlanisJ. Cutaneous manifestations in COVID-19: family cluster of urticarial rash. Clin Exp Dermatol. 2020.doi:10.1111/ced.14290 14 May 2020.32407564
8.
ColonnaC.MonzaniNA.RocchiA.GianottiR.BoggioF.GelmettiC. Chilblain‐like lesions in children following suspected COVID‐19 infection. Pediatr Dermatol. 2020;41(2).doi:10.1111/pde.14210
9.
CordoroKM.ReynoldsSD.WattierR.McCalmontTH. Clustered cases of acral Perniosis: clinical features, histopathology and relationship to COVID-19. Pediatr Dermatol. 2020.doi:10.1111/pde.14227 12 May 2020.32396999
10.
de MassonA.BouazizJ-D.SulimovicLet al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J Am Acad Dermatol. 2020.doi:10.1016/j.jaad.2020.04.161 04 May 2020.32380219
11.
Diaz-GuimaraensB.Dominguez-SantasM.Suarez-ValleAet al. Petechial skin rash associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020.doi:10.1001/jamadermatol.2020.1741 30 Apr 2020.32352487
12.
EhsaniAH.NasimiM.BigdeloZ. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16579 02 May 2020.32359180
13.
EstébanezA.Pérez-SantiagoL.SilvaE.Guillen-ClimentS.García-VázquezA.RamónMD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020;34(6):e250-e251.doi:10.1111/jdv.16474 15 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32294264
14.
Fernandez‐NietoD.Ortega‐QuijanoD.Jimenez‐CauheJet al. Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020doi:10.1111/ced.14277
15.
Galván CasasC.CatalàA.Carretero HernándezGet al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020.doi:10.1111/bjd.19163 29 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32348545
16.
GenoveseG.ColonnaC.MarzanoAV. Varicella‐like exanthem associated with COVID‐19 in an 8‐year‐old girl: a diagnostic clue?Pediatr Dermatol. 2020.doi:10.1111/pde.14201
17.
GianottiR.ZerbiP.Dodiuk-GadRP. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. J Dermatol Sci. 2020.doi:10.1016/j.jdermsci.2020.04.007 30 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32381428
18.
GunawanC.AngelaA.WidysantoA. Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia. J Eur Acad Dermatol Venereol. 2020doi:10.1111/jdv.16622 09 May 2020.http://www.ncbi.nlm.nih.gov/pubmed/32386435
19.
HedouM.CarsuzaaF.CharyE.HainautE.Cazenave-RoblotF.Masson RegnaultM. Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S. J Eur Acad Dermatol Venereol. 2020doi:10.1111/jdv.16519 21 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32314436
HuntM.KoziatekC. A case of COVID-19 pneumonia in a young male with full body rash as a presenting symptom. Clin Pract Cases Emerg Med. 2020
22.
Jimenez-CauheJ.Ortega-QuijanoD.Prieto-BarriosM.Moreno-ArronesOM.Fernandez-NietoD. Reply to “COVID-19 can present with a rash and be mistaken for dengue”: Petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol. 2020doi:10.1016/j.jaad.2020.04.016
23.
Jimenez-CauheJ.Ortega-QuijanoD.Carretero-BarrioIet al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol. 2020doi:10.1111/ced.14281 09 May 2020.http://www.ncbi.nlm.nih.gov/pubmed/32385858
24.
JoobB.WiwanitkitV. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177doi:10.1016/j.jaad.2020.03.036http://www.ncbi.nlm.nih.gov/pubmed/32213305
25.
KalnerS.VergilisIJ. Periorbital erythema as a presenting sign of Covid-19. JAAD Case Rep. 2020doi:10.1016/j.jdcr.2020.05.001 11 05 2020.http://www.ncbi.nlm.nih.gov/pubmed/32395600
26.
KolivrasA.DehavayF.DelplaceDet al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep. 2020;492.doi:10.1016/j.jdcr.2020.04.011 18 04 2020.http://www.ncbi.nlm.nih.gov/pubmed/32363225
27.
LandaN.Mendieta-EckertM.Fonda-PascualP.AguirreT. Chilblain-like lesions on feet and hands during the COVID-19 pandemic. Int J Dermatol. 2020;59(6):739-743.doi:10.1111/ijd.14937http://www.ncbi.nlm.nih.gov/pubmed/32329897
28.
Llamas-VelascoM.Muñoz-HernándezP.Lázaro-GonzálezJet al. Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient. Br J Dermatol. 2020doi:10.1111/bjd.19222 14 May 2020.http://www.ncbi.nlm.nih.gov/pubmed/32407552
29.
LocatelliAG.Robustelli TestE.VezzoliPet al. Histologic features of long‐lasting chilblain‐like lesions in a paediatric COVID‐19 patient. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16617
30.
LuS.LinJ.ZhangZet al. Alert for non-respiratory symptoms of coronavirus disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. 2020.doi:10.1002/jmv.25776 19 Mar 2020.32190904
31.
MahéA.BirckelE.KriegerS.MerklenC.BottlaenderL. A distinctive skin rash associated with coronavirus disease 2019?J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16471 15 Apr 2020.http://www.ncbi.nlm.nih.gov/pubmed/32294259
32.
ManaloIF.SmithMK.CheeleyJ.JacobsR. A dermatologic manifestation of COVID-19: transient Livedo reticularis. J Am Acad Dermatol. 2020.doi:10.1016/j.jaad.2020.04.018
33.
MarzanoAV.GenoveseG.FabbrociniGet al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020.
34.
MazzottaF.TrocciliT. Acute acro-ischemia in the child at the time of COVID-19. Dermatologia Pediatrica. 2020.
35.
Morey-OlivéM.EspiauM.Mercadal-HallyM.Lera-CarballoE.García-PatosV. Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019. An Pediatr. 2020. 17 Apr 2020.doi:10.1016/j.anpedi.2020.04.013http://www.ncbi.nlm.nih.gov/pubmed/32389502
36.
NajarianDJ. Morbilliform exanthem associated with COVID-19. JAAD Case Rep. 2020; doi:10.1016/j.jdcr.2020.04.015 20 04 2020.http://www.ncbi.nlm.nih.gov/pubmed/32313826
37.
PiccoloV.NeriI.FilippeschiCet al. Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol. 2020;10.doi:10.1111/jdv.16526
38.
RecalcatiS. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5).doi:10.1111/jdv.16387
39.
Rodríguez-JiménezP.ChicharroP.De ArgilaD.Muñoz-HernándezP.Llamas-VelascoM. Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16618
40.
SanchezA.SohierP.BenghanemSet al. Digitate Papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020. 30 Apr 2020.doi:10.1001/jamadermatol.2020.1704http://www.ncbi.nlm.nih.gov/pubmed/32352486
41.
TostiG.BarisaniA.QueiroloPet al. Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy. Clin Exp Dermatol. 2020.doi:10.1111/ced.14267 02 May 2020.32358996
42.
van DammeC.BerlinginE.SaussezS.AccaputoO. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16523 24 Apr 2020.32329915
43.
ZengariniC.OrioniG.CascavillaAet al. Histological pattern in Covid-19 induced viral rash. J Eur Acad Dermatol Venereol. 2020.doi:10.1111/jdv.16569 02 May 2020.32358895
44.
GhazalS.LitvinovIV.AljahaniN.JfriA.NetchiporoukE. Cutaneous manifestations of coronavirus disease 2019 (COVID-19) Infection-What do we know so far?J Cutan Med Surg. 2020;1203475420928375:1203475420928375.doi:10.1177/1203475420928375http://www.ncbi.nlm.nih.gov/pubmed/32391713
45.
TangK.WangY.ZhangH.ZhengQ.FangR.SunQ. Cutaneous manifestations of the coronavirus disease 2019 (COVID-19): a brief review. Dermatol Ther. 2020;e13528.doi:10.1111/dth.13528http://www.ncbi.nlm.nih.gov/pubmed/32383234
46.
WollinaU.KaradağAS.Rowland-PayneC.ChiriacA.LottiT. Cutaneous signs in COVID-19 patients: a review. Dermatol Ther. 2020.
47.
GuanWJ.ZYN.HuYet al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.
48.
CappelJA.WetterDA. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of Pernio (chilblains) in a series of 104 patients at Mayo clinic, 2000 to 2011. Mayo Clin Proc. 2014;89(2):207-215.doi:10.1016/j.mayocp.2013.09.020http://www.ncbi.nlm.nih.gov/pubmed/24485134
49.
TakciZ.VahabogluG.EksiogluH. Epidemiological patterns of perniosis, and its association with systemic disorder. Clin Exp Dermatol. 2012;37(8):844-849.doi:10.1111/j.1365-2230.2012.04435.xhttp://www.ncbi.nlm.nih.gov/pubmed/23082992
50.
YangX.PerezOA.EnglishJC. Adult perniosis and cryoglobulinemia: a retrospective study and review of the literature. J Am Acad Dermatol. 2010;62(6):e21-e22.doi:10.1016/j.jaad.2009.10.030http://www.ncbi.nlm.nih.gov/pubmed/20466166
51.
SimonTD.SoepJB.HollisterJR. Pernio in pediatrics. Pediatrics. 2005;116(3):e472-e475.doi:10.1542/peds.2004-2681http://www.ncbi.nlm.nih.gov/pubmed/16140694
52.
IvashkivLB.DonlinLT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36-49.doi:10.1038/nri3581http://www.ncbi.nlm.nih.gov/pubmed/24362405
53.
CruzAT.ZeichnerSL. COVID-19 in children: initial characterization of the pediatric disease. Pediatrics. 2020;145(6):e20200834.doi:10.1542/peds.2020-0834 16 03 2020.http://www.ncbi.nlm.nih.gov/pubmed/32179659
MagroC.MulveyJJ.BerlinDet al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:13.doi:10.1016/j.trsl.2020.04.007 15 Apr 2020.32299776
56.
YaoXH.TYL.ZCHet al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(0):E009.
57.
WangML.ChanMP. Comparative analysis of chilblain lupus erythematosus and idiopathic Perniosis: histopathologic features and immunohistochemistry for CD123 and CD30. Am J Dermatopathol. 2018;40(4):265-271.doi:10.1097/DAD.0000000000000945http://www.ncbi.nlm.nih.gov/pubmed/28719438
58.
FretzayasA.DourosK.MoustakiM.NicolaidouP. Papular-purpuric gloves and socks syndrome in children and adolescents. Pediatr Infect Dis J. 2009;28(3):250-252.doi:10.1097/INF.0b013e31818cb289http://www.ncbi.nlm.nih.gov/pubmed/19165131
59.
GrilliR.IzquierdoMJ.FariñaMCet al. Papular-purpuric "gloves and socks" syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol. 1999;41(5 Pt 1):793-796.doi:10.1016/S0190-9622(99)70027-7http://www.ncbi.nlm.nih.gov/pubmed/10534650
60.
FeldmannR.HarmsM.SauratJH. Papular-purpuric 'gloves and socks' syndrome: not only parvovirus B19. Dermatology. 1994;188(2):85-87.doi:10.1159/000247106http://www.ncbi.nlm.nih.gov/pubmed/8136553
61.
BerengerBM.FonsecaK.SchneiderAR.HuJ.ZelyasN. Sensitivity of nasopharyngeal, nasal and throat swab for the detection of SARS-CoV-2. medRxiv. 2020.
62.
RathjenNA.ShahbodaghiSD.BrownJA. Hypothermia and cold weather injuries. Am Fam Physician. 2019;100(11):680-686.http://www.ncbi.nlm.nih.gov/pubmed/31790182
63.
CoulombeJ.PowellJ.HatamiA.McCuaigC.RenetS.MarcouxD. Diseases of abnormal sensitivity to cold in children on psychostimulant drugs. J Cutan Med Surg. 2015;19(2):121-124.doi:10.2310/7750.2014.14052http://www.ncbi.nlm.nih.gov/pubmed/25775630
64.
FlammerJR.DobrovolnaJ.KennedyMAet al. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol Cell Biol. 2010;30(19):4564-4574.doi:10.1128/MCB.00146-10http://www.ncbi.nlm.nih.gov/pubmed/20679482
65.
SouwerIH.BorJH.SmitsP.Lagro-JanssenAL. Assessing the effectiveness of topical betamethasone to treat chronic chilblains: a randomised clinical trial in primary care. Br J Gen Pract. 2017;67(656):e187-e193.doi:10.3399/bjgp17X689413http://www.ncbi.nlm.nih.gov/pubmed/28193616
66.
RustinMH.NewtonJA.SmithNP.DowdPM. The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol. 1989;120(2):267-275.doi:10.1111/j.1365-2133.1989.tb07792.xhttp://www.ncbi.nlm.nih.gov/pubmed/2647123
67.
VermaP.SingalA.YadavP. Perniosis in an infant treated with topical nitroglycerine. Pediatr Dermatol. 2013;30(5):623-624.doi:10.1111/pde.12133http://www.ncbi.nlm.nih.gov/pubmed/23551545
68.
PatraAK.DasAL.RamadasanP. Diltiazem vs. nifedipine in chilblains: a clinical trial. Indian J Dermatol Venereol Leprol. 2003;69(3):209-211.http://www.ncbi.nlm.nih.gov/pubmed/17642888
69.
YangX.PerezOA.EnglishJC. Successful treatment of perniosis with hydroxychloroquine. J Drugs Dermatol. 2010;9(10):1242-1246.http://www.ncbi.nlm.nih.gov/pubmed/20941949
70.
NoaimiAA.FadheelBM. Treatment of perniosis with oral pentoxyfylline in comparison with oral prednisolone plus topical clobetasol ointment in Iraqi patients. Saudi Med J. 2008;29(12):1762-1764.http://www.ncbi.nlm.nih.gov/pubmed/19082229
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
